Oral and intravenous ibandronate are effective in preventing postmenopausal bone loss when given continuously and intermittently with extended between-dose intervals

被引：0
|
作者：
Epstein, S
Stakkestad, JA
McClung, M
Burdeska, A
Mahoney, P
Adachi, J
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] CECOR AS, Haugesund, Norway
[3] Oregon Osteoporosis Ctr, Portland, OR USA
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] McMaster Univ, Hamilton, ON, Canada
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 5 条
  • [1] Oral ibandronate produces significant antifracture efficacy when given intermittently with a between-dose interval of >2 months
    Felsenberg, D
    Halse, J
    Skag, A
    Gilbride, J
    Schimmer, RC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 97 - 97
  • [2] Antifracture efficacy of oral ibandronate given with a between-dose interval of >2 months in postmenopausal osteoporosis
    Delmas, PD
    Recker, RR
    Stakkestad, JA
    Chesnut, CH
    Christiansen, C
    Hoiseth, A
    Gilbride, J
    Schimmer, RC
    [J]. BONE, 2003, 32 (05) : S208 - S209
  • [3] Intermittent intravenous ibandronate injections: A new therapeutic option for preventing postmenopausal bone loss
    Stakkestad, JA
    Stepan, JJ
    Skag, A
    Burdeska, A
    Jonkanski, I
    Mahoney, P
    [J]. BONE, 2003, 32 (05) : S79 - S80
  • [4] Both oral and intravenous ibandronate effectively prevent postmenopausal bone loss in women without osteoporosis.
    Adachi, JD
    Christiansen, C
    Stakkestad, JA
    McClung, M
    Burdeska, A
    Mahoney, P
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S372 - S372
  • [5] Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women
    Stakkestad, JA
    Benevolenskaya, LI
    Stepan, JJ
    Skag, A
    Nordby, A
    Oefjord, E
    Burdeska, A
    Jonkanski, I
    Mahoney, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (10) : 969 - 975
1